Sinopharm Schedules 18 June 2026 Domestic Shareholders’ Meeting to Seek H-Share Repurchase Mandate

Bulletin Express05-28

Sinopharm Group Co. Ltd. has issued a formal proxy form and meeting notice to its domestic shareholders ahead of a class meeting set for 10:15 a.m. on Thursday, 18 June 2026. The session will be held in Meeting Room 1401 of Sinopharm Group Building, No. 385 East Longhua Road, Huangpu District, Shanghai, China.

The sole agenda item is a special resolution authorising the Board to obtain a general mandate for the repurchase of the company’s H Shares. The proposal, details of which were previously circulated on 28 May 2026, seeks shareholder approval to empower directors to execute share buy-backs within limits stipulated by applicable regulations.

Domestic shareholders may attend in person or appoint proxies. If designating someone other than the meeting chairman, shareholders must complete and submit the proxy form—together with any notarised authorisation—no later than 24 hours before the meeting’s scheduled start. In cases of joint shareholding, only the first-named holder in the register is entitled to vote.

The meeting is expected to last less than half a day; attendees are responsible for their own transport and accommodation costs and must present valid identification upon arrival.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1109515323?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 06:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109515323","market":"us","top_or_hot":-1,"title":"Sinopharm Schedules 18 June 2026 Domestic Shareholders’ Meeting to Seek H-Share Repurchase Mandate","media":"Bulletin Express","content":"<p>Sinopharm Group Co. Ltd. has issued a formal proxy form and meeting notice to its domestic shareholders ahead of a class meeting set for 10:15 a.m. on Thursday, 18 June 2026. The session will be held in Meeting Room 1401 of Sinopharm Group Building, No. 385 East Longhua Road, Huangpu District, Shanghai, China.</p>\n<p>The sole agenda item is a special resolution authorising the Board to obtain a general mandate for the repurchase of the company’s H Shares. The proposal, details of which were previously circulated on 28 May 2026, seeks shareholder approval to empower directors to execute share buy-backs within limits stipulated by applicable regulations.</p>\n<p>Domestic shareholders may attend in person or appoint proxies. If designating someone other than the meeting chairman, shareholders must complete and submit the proxy form—together with any notarised authorisation—no later than 24 hours before the meeting’s scheduled start. In cases of joint shareholding, only the first-named holder in the register is entitled to vote.</p>\n<p>The meeting is expected to last less than half a day; attendees are responsible for their own transport and accommodation costs and must present valid identification upon arrival.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinopharm Schedules 18 June 2026 Domestic Shareholders’ Meeting to Seek H-Share Repurchase Mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinopharm Schedules 18 June 2026 Domestic Shareholders’ Meeting to Seek H-Share Repurchase Mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-28 06:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinopharm Group Co. Ltd. has issued a formal proxy form and meeting notice to its domestic shareholders ahead of a class meeting set for 10:15 a.m. on Thursday, 18 June 2026. The session will be held in Meeting Room 1401 of Sinopharm Group Building, No. 385 East Longhua Road, Huangpu District, Shanghai, China.</p>\n<p>The sole agenda item is a special resolution authorising the Board to obtain a general mandate for the repurchase of the company’s H Shares. The proposal, details of which were previously circulated on 28 May 2026, seeks shareholder approval to empower directors to execute share buy-backs within limits stipulated by applicable regulations.</p>\n<p>Domestic shareholders may attend in person or appoint proxies. If designating someone other than the meeting chairman, shareholders must complete and submit the proxy form—together with any notarised authorisation—no later than 24 hours before the meeting’s scheduled start. In cases of joint shareholding, only the first-named holder in the register is entitled to vote.</p>\n<p>The meeting is expected to last less than half a day; attendees are responsible for their own transport and accommodation costs and must present valid identification upon arrival.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01099","symbol_name":"国药控股","start_time":0,"source_url":"","article_id":"1109515323","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109515323","pubTimestamp":1779921790,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinopharm Group Co. Ltd. has issued a formal proxy form and meeting notice to its domestic shareholders ahead of a class meeting set for 10:15 a.m. on Thursday, 18 June 2026. The session will be held...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01099":"国药控股"},"translate_title":"国药控股定于2026年6月18日召开内资股股东大会寻求H股回购授权","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"Sinopharm Group Co. Ltd. has issued a formal proxy form and meeting notice to its domestic shareholders ahead of a class meeting set for 10:15 a.m. on Thursday, 18 June 2026. The session will be held in Meeting Room 1401 of Sinopharm Group Building, No. 385 East Longhua Road, Huangpu District, Shanghai, China.\nThe sole agenda item is a special resolution authorising the Board to obtain a general mandate for the repurchase of the company’s H Shares. The proposal, details of which were previously circulated on 28 May 2026, seeks shareholder approval to empower directors to execute share buy-backs within limits stipulated by applicable regulations.\nDomestic shareholders may attend in person or appoint proxies. If designating someone other than the meeting chairman, shareholders must complete and submit the proxy form—together with any notarised authorisation—no later than 24 hours before the meeting’s scheduled start. In cases of joint shareholding, only the first-named holder in the register is entitled to vote.\nThe meeting is expected to last less than half a day; attendees are responsible for their own transport and accommodation costs and must present valid identification upon arrival.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1109515323","isCrawlerRequest":true}